Takeda (TSE:4502/NYSE:TAK) announced new data from VERDICT (NCT04259138), showing that treating adults with intravenous ...
In a Phase 2a study, ABBV-466 achieved higher endoscopic remission rates in patients with Crohn's disease than either anti-IL-23 p19 or anti-α4β7 monotherapy at Week 12, the primary ...
One-year results from SHINE-2 in children and adolescents with ulcerative colitis Of the patients enrolled in SHINE-2, 81% achieved clinical response at Week 12. Among responders, ages 6 to 17, ...
Skyrizi (risankizumab) is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for ...
Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete ...
AbbVie (NYSE: ABBV) presented 20 scientific abstracts from its inflammatory bowel disease portfolio at the 2026 United ...
Paramus, N.J.-based Valley Health System has established a graduate medical education fellowship program in gastroenterology. The health system is launching the program in partnership with the Icahn ...
A total of 257 seats are available in DM Medical Gastroenterology, 111 seats in MCh Surgical Gastroenterology and 6 in DM ...
Individuals who received notice of the 2024 Washington Gastroenterology data breach may be eligible to claim up to $4,000 from a class action settlement.
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for SBS-IF ...
Featured science includes endurance running and ischemic colitis, AI recognition of emergencies in different languages, sleep quality vs. sleep duration and MASLD risk, and assisted reproductive techn ...
PopH, MACG, was elected as the 2026–2027 President of the American College of Gastroenterology (ACG), a national medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results